Tandem Diabetes Care Inc. (TNDM)

59.18
NASDAQ : Health Technology
Prev Close 58.76
Day Low/High 59.16 / 61.10
52 Wk Low/High 26.40 / 74.81
Avg Volume 1.32M
Exchange NASDAQ
Shares Outstanding 58.65M
Market Cap 3.45B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Tandem Diabetes Care Announces No-Cost Software Updates For T:slim X2 Insulin Pump Customers In The United States

Tandem Diabetes Care Announces No-Cost Software Updates For T:slim X2 Insulin Pump Customers In The United States

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it is offering no-cost feature updates for t:slim X2 insulin pump customers in the United States through the end of 2020.

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Jim Cramer says higher sales, higher prices, and demand from emerging markets seem to be fueling a return to the days of great senior growth stocks.

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Jim Cramer weighs in on Pfizer, eBay, Cloudera, Cadence Systems, CRISPR Therapeutics, Moderna, Tandem Diabetes Care, and more.

Notable Friday Option Activity: TNDM, CRCM, GM

Notable Friday Option Activity: TNDM, CRCM, GM

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tandem Diabetes Care Inc , where a total of 5,176 contracts have traded so far, representing approximately 517,600 underlying shares. That amounts to about 49.9% of TNDM's average daily trading volume over the past month of 1.0 million shares.

Tandem Diabetes Care To Announce Second Quarter 2019 Financial Results On August 1, 2019

Tandem Diabetes Care To Announce Second Quarter 2019 Financial Results On August 1, 2019

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2019 results after the financial markets close on Thursday, August 1, 2019.

Tandem Diabetes Care Announces Upcoming Conference Presentation

Tandem Diabetes Care Announces Upcoming Conference Presentation

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present at the BMO 2019 Prescriptions for Success Healthcare Conference...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Tandem Diabetes Care, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Tandem Diabetes Care, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

NEW YORK, June 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Tandem...

Tandem Diabetes Care Reports Positive Results From Two Studies Of The T:slim X2 Insulin Pump With Control-IQ Technology

Tandem Diabetes Care Reports Positive Results From Two Studies Of The T:slim X2 Insulin Pump With Control-IQ Technology

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced positive results from two studies of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology.

Tandem Diabetes Care Announces Conference Call Following Data Presentations At The ADA Scientific Sessions

Tandem Diabetes Care Announces Conference Call Following Data Presentations At The ADA Scientific Sessions

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will hold a conference call on Sunday, June 9, 2019 at 8:00pm Eastern Time (5:00pm Pacific Time) following data...

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a Company update at the following upcoming investor conferences: Bank of America Merrill Lynch Healthcare...

Tandem Diabetes Care Announces First Quarter 2019 Financial Results And Updated 2019 Financial Guidance

Tandem Diabetes Care Announces First Quarter 2019 Financial Results And Updated 2019 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2019 and updated its financial guidance for the year ending December 31, 2019.

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at DexCom, HCA Healthcare, Tractor Supply, Sarepta Therapeutics, The Blackstone Group, HNI Corp. and more.

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Jim Cramer says it's the start CNBC's annual Stock Draft Contest, but he cautions Mad Money viewers that although investing can be fun, it requires discipline and doing your homework.

Tandem Diabetes Care To Announce First Quarter 2019 Financial Results On April 30, 2019

Tandem Diabetes Care To Announce First Quarter 2019 Financial Results On April 30, 2019

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2019 results after the financial markets close on Tuesday, April 30, 2019.

Bankers on the Grill: Cramer's 'Mad Money' Recap (Wednesday 4/10/19)

Bankers on the Grill: Cramer's 'Mad Money' Recap (Wednesday 4/10/19)

Averages barely budge, despite grilling of banking CEOS by lawmakers. Jim Cramer talks about earnings and the great divide in Washington.

Yeti holdings, Tandem Diabetes, Electronic Arts: 'Mad Money' Lightning Round

Yeti holdings, Tandem Diabetes, Electronic Arts: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Yeti holdings, Tandem Diabetes Care, Electronic Arts, Aurora Cannabis, PacWest Bancorp and more.

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

Apple couldn't do much to hold back the bears today, but Jim Cramer says the company's services segment is the most important thing and he's more than happy with it.

Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle

Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle

What would the people who help determine AAPL's stock price really want?

Playbook for the Fed: Cramer's 'Mad Money' Recap (Thursday 3/21/19)

Playbook for the Fed: Cramer's 'Mad Money' Recap (Thursday 3/21/19)

Jim Cramer has a playbook for finding the stocks that can make money without the economy filling the sails.

Berkshire Hathaway, Callaway Golf, Microsoft: 'Mad Money' Lightning Round

Berkshire Hathaway, Callaway Golf, Microsoft: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Berkshire Hathaway, Callaway Golf, Whitestone, Microsoft, Centene and more.

Jim Cramer Won't Buy Apple Stock at Current Prices Unless the Company Does This

Jim Cramer Won't Buy Apple Stock at Current Prices Unless the Company Does This

The stock is just too expensive here ... unless the company buys these two medical-devices companies.

Look Out for an Intraday Reversal in the Market

Look Out for an Intraday Reversal in the Market

Some momentum movers are becoming extended and have seen profit-taking Monday.

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Tandem Diabetes Care Approved As Insulin Pump Vendor For ADP In Ontario, Canada

Tandem Diabetes Care Approved As Insulin Pump Vendor For ADP In Ontario, Canada

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario,...

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present at the following upcoming investor conferences: Cowen 39 th...

Tandem Diabetes Care Announces Plan To Use Remote Software Update Tool In Ongoing Clinical Trial

Tandem Diabetes Care Announces Plan To Use Remote Software Update Tool In Ongoing Clinical Trial

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly...

A Technical Strategy for Tandem Diabetes Care

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?

TheStreet Quant Rating: D- (Sell)